• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia

tetano

Editor, Senior Moderator
PLoS One. 2018 Jan 10;13(1):e0190947. doi: 10.1371/journal.pone.0190947. eCollection 2018.
[h=1]Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.[/h] Tarigan S[SUP]1[/SUP], Wibowo MH[SUP]2[/SUP], Indriani R[SUP]1[/SUP], Sumarningsih S[SUP]1[/SUP], Artanto S[SUP]2[/SUP], Idris S[SUP]3[/SUP], Durr PA[SUP]4[/SUP], Asmara W[SUP]2[/SUP], Ebrahimie E[SUP]5[/SUP], Stevenson MA[SUP]6[/SUP], Ignjatovic J[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Although vaccination of poultry for control of highly pathogenic avian influenza virus (HPAIV) H5N1 has been practiced during the last decade in several countries, its effectiveness under field conditions remains largely unquantified. Effective HPAI vaccination is however essential in preventing incursions, silent infections and generation of new H5N1 antigenic variants. The objective of this study was to asses the level and duration of vaccine induced immunity in commercial layers in Indonesia. Titres of H5N1 haemagglutination inhibition (HI) antibodies were followed in individual birds from sixteen flocks, age 18-68 week old (wo). The study revealed that H5N1 vaccination had highly variable outcome, including vaccination failures, and was largely ineffective in providing long lasting protective immunity. Flocks were vaccinated with seven different vaccines, administer at various times that could be grouped into three regimes: In regime A, flocks (n = 8) were vaccinated two or three times before 19 wo; in regime B (n = 2), two times before and once after 19 wo; and in regime C (n = 6) three to four times before and two to three times after 19 wo. HI titres in regime C birds were significantly higher during the entire observation period in comparison to titres of regime A or B birds, which also differed significantly from each other. The HI titres of individual birds in each flock differed significantly from birds in other flocks, indicating that the effectiveness of field vaccination was highly variable and farm related. Protective HI titres of >4log2, were present in the majority of flocks at 18 wo, declined thereafter at variable rate and only two regime C flocks had protective HI titres at 68 wo. Laboratory challenge with HPAIV H5N1 of birds from regime A and C flocks confirmed that protective immunity differed significantly between flocks vaccinated by these two regimes. The study revealed that effectiveness of the currently applied H5N1 vaccination could be improved and measures to achieve this are discussed.


PMID: 29320563 DOI: 10.1371/journal.pone.0190947
Free full text
 
Back
Top Bottom